136 related articles for article (PubMed ID: 10528222)
21. Regulation of Graves' hyperthyroidism with naturally occurring CD4+CD25+ regulatory T cells in a mouse model.
Saitoh O; Nagayama Y
Endocrinology; 2006 May; 147(5):2417-22. PubMed ID: 16439459
[TBL] [Abstract][Full Text] [Related]
22. Thyrotropin Receptor-Specific Lymphocytes in Adenovirus-TSHR-Immunized Native and Human Leukocyte Antigen-DR3-Transgenic Mice and in Graves' Disease Patient Blood.
Degen H; Gavvovidis I; Blankenstein T; Uhland K; Ungerer M
Thyroid; 2021 Jun; 31(6):950-963. PubMed ID: 33208049
[No Abstract] [Full Text] [Related]
23. Evidence that factors other than particular thyrotropin receptor T cell epitopes contribute to the development of hyperthyroidism in murine Graves' disease.
Pichurin PN; Chen CR; Nagayama Y; Pichurina O; Rapoport B; McLachlan SM
Clin Exp Immunol; 2004 Mar; 135(3):391-7. PubMed ID: 15008970
[TBL] [Abstract][Full Text] [Related]
24. Differential requirement of signal transducer and activator of transcription-4 (Stat4) and Stat6 in a thyrotropin receptor-289-adenovirus-induced model of Graves' hyperthyroidism.
Land KJ; Gudapati P; Kaplan MH; Seetharamaiah GS
Endocrinology; 2006 Jan; 147(1):111-9. PubMed ID: 16195404
[TBL] [Abstract][Full Text] [Related]
25. Graves' disease in severe combined immunodeficient mice.
Soliman M; Kaplan E; Straus F; Fisfalen ME; Hidaka Y; Guimaraes V; DeGroot LJ
J Clin Endocrinol Metab; 1995 Oct; 80(10):2848-55. PubMed ID: 7559863
[TBL] [Abstract][Full Text] [Related]
26. Critical Differences between Induced and Spontaneous Mouse Models of Graves' Disease with Implications for Antigen-Specific Immunotherapy in Humans.
Rapoport B; Banuelos B; Aliesky HA; Hartwig Trier N; McLachlan SM
J Immunol; 2016 Dec; 197(12):4560-4568. PubMed ID: 27913646
[TBL] [Abstract][Full Text] [Related]
27. Generation of a transgenic animal model of hyperthyroid Graves' disease.
Kim-Saijo M; Akamizu T; Ikuta K; Iida Y; Ohmori K; Matsubara K; Matsuda Y; Suzuki M; Matsuda F; Nakao K
Eur J Immunol; 2003 Sep; 33(9):2531-8. PubMed ID: 12938229
[TBL] [Abstract][Full Text] [Related]
28. Genetic immunization of outbred mice with thyrotropin receptor cDNA provides a model of Graves' disease.
Costagliola S; Many MC; Denef JF; Pohlenz J; Refetoff S; Vassart G
J Clin Invest; 2000 Mar; 105(6):803-11. PubMed ID: 10727449
[TBL] [Abstract][Full Text] [Related]
29. Prevention of autoantibody-mediated Graves'-like hyperthyroidism in mice with IL-4, a Th2 cytokine.
Nagayama Y; Mizuguchi H; Hayakawa T; Niwa M; McLachlan SM; Rapoport B
J Immunol; 2003 Apr; 170(7):3522-7. PubMed ID: 12646613
[TBL] [Abstract][Full Text] [Related]
30. Immunization of mice with a newly identified thyroid-stimulating hormone receptor splice variant induces Graves'-like disease.
Endo T; Kobayashi T
J Autoimmun; 2013 Jun; 43():18-25. PubMed ID: 23538203
[TBL] [Abstract][Full Text] [Related]
31. Thyrotropin receptor autoantibodies in Graves' disease.
Schott M; Scherbaum WA; Morgenthaler NG
Trends Endocrinol Metab; 2005 Jul; 16(5):243-8. PubMed ID: 15950483
[TBL] [Abstract][Full Text] [Related]
32. CD8+CD122+ T cells, a newly identified regulatory T subset, negatively regulate Graves' hyperthyroidism in a murine model.
Saitoh O; Abiru N; Nakahara M; Nagayama Y
Endocrinology; 2007 Dec; 148(12):6040-6. PubMed ID: 17823258
[TBL] [Abstract][Full Text] [Related]
33. Induction of thyroid-stimulating hormone receptor autoimmunity in hamsters.
Ando T; Imaizumi M; Graves P; Unger P; Davies TF
Endocrinology; 2003 Feb; 144(2):671-80. PubMed ID: 12538630
[TBL] [Abstract][Full Text] [Related]
34. HLA-DR3 transgenic mice immunized with adenovirus encoding the thyrotropin receptor: T cell epitopes and functional analysis of the CD40 Graves' polymorphism.
Pichurin P; Pham N; David CS; Rapoport B; McLachlan SM
Thyroid; 2006 Dec; 16(12):1221-7. PubMed ID: 17199432
[TBL] [Abstract][Full Text] [Related]
35. Hyperthyroid monkeys: a nonhuman primate model of experimental Graves' disease.
Wang Y; Wu LP; Fu J; Lv HJ; Guan XY; Xu L; Chen P; Gao CQ; Hou P; Ji MJ; Shi BY
J Endocrinol; 2013 Dec; 219(3):183-93. PubMed ID: 24029729
[TBL] [Abstract][Full Text] [Related]
36. Toxicology and Carcinogenesis Studies of Mercuric Chloride (CAS No. 7487-94-7) in F344 Rats and B6C3F1 Mice (Gavage Studies).
National Toxicology Program
Natl Toxicol Program Tech Rep Ser; 1993 Feb; 408():1-260. PubMed ID: 12621522
[TBL] [Abstract][Full Text] [Related]
37. Experimental model for ophthalmopathy in BALB/c and outbred (CD-1) mice genetically immunized with G2s and the thyrotropin receptor.
Yamada M; Li AW; West KA; Chang CH; Wall JR
Autoimmunity; 2002 Sep; 35(6):403-13. PubMed ID: 12568121
[TBL] [Abstract][Full Text] [Related]
38. Experimental autoimmunity to thyrotropin receptor.
Patibandla SA; Wagle NM; Seetharamaiah GS; Fan JL; Dallas JS; Prabhakar BS
Exp Clin Endocrinol Diabetes; 1996; 104 Suppl 3():28-32. PubMed ID: 8986417
[TBL] [Abstract][Full Text] [Related]
39. Genetic immunization against the human thyrotropin receptor causes thyroiditis and allows production of monoclonal antibodies recognizing the native receptor.
Costagliola S; Rodien P; Many MC; Ludgate M; Vassart G
J Immunol; 1998 Feb; 160(3):1458-65. PubMed ID: 9570567
[TBL] [Abstract][Full Text] [Related]
40. Simultaneous induction of Graves' hyperthyroidism and Graves' ophthalmopathy by TSHR genetic immunization in BALB/c mice.
Xia N; Ye X; Hu X; Song S; Xu H; Niu M; Wang H; Wang J
PLoS One; 2017; 12(3):e0174260. PubMed ID: 28319174
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
